| CTRI Number |
CTRI/2022/07/044401 [Registered on: 27/07/2022] Trial Registered Prospectively |
| Last Modified On: |
11/07/2022 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Dentistry |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
A Clinical Trial to study the healing of extraction socket and implant stability on using a naturally sourced bone graft |
|
Scientific Title of Study
|
Evaluation of healing of extraction socket, bone morphologic changes, primary implant stability and patient reported outcome measures with the use of E-Bone (naturally sourced nano-hydroxyapatite graft): A Randomized Control Trial |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Pragati Kaurani |
| Designation |
Professor, Department of Prosthodontics, Crown and Bridge |
| Affiliation |
Mahatma Gandhi Dental College and Hospital |
| Address |
Mahatma Gandhi Dental College and Hospital, Department of Prosthododntics, Crown and Brisge, MGUMST, RIICO Industrial Area, Sitapura, Jaipur
Jaipur RAJASTHAN 302022 India |
| Phone |
9829663314 |
| Fax |
|
| Email |
drpragati@mgumst.org |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Vivekanand Kattimani |
| Designation |
Head of Department, Dept of Clinical Research, Professor, Dept of Oral and Maxillofacial Surgery |
| Affiliation |
Sibar Institute of Dental Sciences |
| Address |
Department of Clinical Research, Sibar Institute of Dental Sciences, Guntur- 522509
NSS- Program Coordinator, Dr. N.T.R. University of Health Science, Andhra Pradesh, India
Guntur ANDHRA PRADESH 522509 India |
| Phone |
9492473628 |
| Fax |
|
| Email |
drvivekanandsk@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Pragati Kaurani |
| Designation |
Professor, Department of Prosthodontics, Crown and Bridge |
| Affiliation |
Mahatma Gandhi Dental College and Hospital |
| Address |
Mahatma Gandhi Dental College and Hospital, Department of Prosthodontics, Crown and Bridge, MGUMST, RIICO Industrial Area, Sitapura, Jaipur
Jaipur RAJASTHAN 302022 India |
| Phone |
9829663314 |
| Fax |
|
| Email |
drpragati@mgumst.org |
|
|
Source of Monetary or Material Support
|
| Mahatma Gandhi Dental College and Hospital, Sitapura Jaipur |
|
|
Primary Sponsor
|
| Name |
Mahatma Gandhi Dental College and Hospital |
| Address |
MGUMST, RIICO Industrial Area, Sitapura, Jaipur- 302022 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Dr Girija EK |
Periyar University, Salem |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Pragati Kaurani |
Mahatma Gandhi Dental College and Hopsital |
Department of Prosthodontics, Crown and Bridge, MGUMST, RIICO Industrial Area, Sitapura, Jaipur Jaipur RAJASTHAN |
9929663314 0141-2770326 drpragati@mgumst.org |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K080||Exfoliation of teeth due to systemic causes, (2) ICD-10 Condition: K088||Other specified disorders of teethand supporting structures, (3) ICD-10 Condition: K083||Retained dental root, (4) ICD-10 Condition: K085||Unsatisfactory restoration of tooth, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Egg shell derived nano hydoxyapatite biomaterial |
Dose-as needed to fill the defect approximately 1gm for socket to fill in molar and 0.5gm for other teeth
Duration- One time implantation |
| Comparator Agent |
No treatment provided to the extraction socket. |
No treatment shall be provided to the extraction socket and shall heal normally. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
45.00 Year(s) |
| Gender |
Both |
| Details |
1. Patients who had teeth with indication for extraction, with extensive cavities, root fracture or vertical periodontal defects of maxillary or mandibular first and second molars.2. Patients in whom single or multiple teeth were indicated for extraction for reasons other than chronic periodontitis.3. Patients with age 18-45 years with good oral hygiene and teeth in need of extraction in regions where the use of a temporary prosthesis or mucosal support was not necessary shall be recruited. |
|
| ExclusionCriteria |
| Details |
1. Smokers, ASA III and IV, pregnant women, patients with Stage III or IV periodontal disease will be excluded from the study.
2. Patients with gross tooth mobility due to complete bone loss (more than 3/4 of root length).
3. Patients with any abnormal findings during clinical or radiological examination. Example: Patients with ankylosed roots or other root morphological alterations that may complicate the procedure.
4. Patients undergoing Immunosuppressive conditions such as AIDS, Cancer or Radiation therapies.
5. Subjects with positive COVID results.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Assessment of the bone quality and bone dimensions and assessment of primary stability of implant |
4 months after tooth extraction surgery |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Pain |
At time of implant placement (4 months after tooth extraction surgery) |
| Number of consultation |
At time of implant placement (4 months after tooth extraction surgery) |
| Recommendation of patient |
At time of implant placement (4 months after tooth extraction surgery) |
| Treatment difficulty |
At time of implant placement (4 months after tooth extraction surgery) |
| Histomorphic Evaluation |
At time of implant placement (4 months after tooth extraction surgery) |
|
|
Target Sample Size
|
Total Sample Size="26" Sample Size from India="26"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/08/2022 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
NIL |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This Study is a single centered, randomized control trial. Aim:The aim of this study is to evaluate the bone changes, primary stability and patient reported outcome measures on placing egg shell derived nanohydroxyapatite bone grafting material into an extraction socket followed by implant placement. Objectives: 1. To evaluate the bone changes (radiographic and histomorphic) on placement of the nano-hydroxyapatite egg shell derived biomaterial in the extraction socket followed by implant placement. 2. To evaluate the primary stability of the implants placed in the implant site formed on placement of the nano-hydroxyapatite egg shell derived biomaterial using a Osstell ISQ RFA device. 3. To evaluate the patient reported outcome measures for the surgical procedures involving socket preservation and implant placement using the nano-hydroxyapatite egg shell derived biomaterial. Material and Method: Patients shall be selected from the OPD of Department of Prosthodontics and Oral and Maxillofacial Surgery. After the extraction of the indicated tooth, the patients shall be randomly assigned into two groups: to the Test group 1 (Control group) the Test group 2 (Interventional Group). For the TG2, the sockets shall be filled with the egg shell derived nano-hydroxyapatite biomaterial up to the original level of the alveolar ridge; For the TG1, pressure pack is applied and allowed to be filled by clotting that will be allowed to form naturally. Nano-hydroxyapatite Graft Material used for grafting are synthesized from natural calcium precursors obtained from chicken eggshell waste and produced using a rapid microwave processing technique. Extraction of the tooth or tooth root will be performed atraumatically under local anesthesia. If necessary, curettage shall be performed and irrigation will be done with Betadine and saline. After hemostasis, nHA grafting will be performed to the crestal level in the TG2 group and buccal advancement flap will be used for primary closure of the site using 4.0 non absorbable polyamide sutures. Postoperative care for both the groups shall include continued 500 mg amoxicillin+ 125mg Clavulenic Acid every 12 hr for 5 days and Aceclofenac 100mg +Serratiopeptidase 15mg + Paracetamol 325 mg twice daily for 5 days, as well as use of the mouthwash with 0.12% chlorhexidine two times a day for 14 days. After sevendays, the sutures shall be removed. Patients shall be instructed to use ice bags on the surgical region within 48 h after surgeries and to eat only soft and cold food during this period. Four months after tooth extraction surgery, implant planning shall be done. The following shall be evaluated for each patient in both the groups: radiographic bone density, bone height and width. The data from the CBCT shall be further be used for implant planning and assessment. Assessment of the bone quality and bone dimensions shall be done by a single blinded assessor who shall not be involved in the graft placement. Surgical placement of the implant shall be done by one trained operator who shall be blinded for the groups. Primary stability of the implant placed shall be recorded for each patient by the same blinded operator by using Osstell ISQ RFA device. Referance articles 1. SureshKumar G, Thamizhavel A, Girija EK. Microwave conversion of eggshells into flower-like hydroxyapatite nanostructure for biomedical applications. Mater Lett 2012;76:198-200. 2. Kattimani VS, Lingamaneni KP, Kreedapathi GE, Kattappagari KK. Socket preservation using eggshellderived nanohydroxyapatite with platelet-rich fibrin as a barrier membrane: a new technique. J Korean Assoc Oral Maxillofac Surg 2019;45:332-342. https://doi.org/10.5125/jkaoms.2019.45.6.332 3. Kattimani VS, Prathigudupu RS, et al. Role of Synthetic Hydroxyapatite—In Socket Preservation: A Systematic Review and Meta-analysis. J Contemp Dent Pract 2019;20(8):987–993. |